for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Corbus Pharma Reports Last Subject Visit In Phase 2B Study Of Lenabasum For Treatment Of Cystic Fibrosis

June 22 (Reuters) - Corbus Pharmaceuticals Holdings Inc :

* CORBUS PHARMACEUTICALS REPORTS LAST SUBJECT VISIT IN PHASE 2B STUDY OF LENABASUM FOR TREATMENT OF CYSTIC FIBROSIS

* CORBUS PHARMACEUTICALS HOLDINGS INC - TOPLINE DATA FOR LENABASUM ON SCHEDULE FOR Q3 2020 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up